AI Discovers Novel Weight-Loss Molecule Rivaling Ozempic, Without Side Effects
2025-03-07
Stanford Medicine researchers, using an AI algorithm, have identified a naturally occurring molecule, BRP, that rivals semaglutide (Ozempic) in suppressing appetite and reducing body weight. Importantly, animal testing showed BRP avoids side effects like nausea, constipation, and muscle loss. BRP acts through a distinct but similar metabolic pathway, targeting the hypothalamus to control appetite. A company has been formed to launch human clinical trials. This breakthrough relied on AI to sift through thousands of proteins, offering a promising new avenue for obesity treatment.